Xenon Pharmaceuticals Cash Flow Statement (2013-2025) | XENE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-15.76M	-22.11M	-15.45M	-25.56M	-19.67M	-31.16M	-37.15M	83.90M	-41.73M	-47.46M	-48.46M	129.75M	-47.93M	-57.92M	-62.79M	-70.68M	-65.05M	-84.71M	-90.90M	-111.43M
Share-based Compensation (Quarter)	1.97M	2.70M	2.64M	2.71M	3.61M	5.21M	5.74M	5.81M	5.99M	8.45M	8.74M	9.18M	9.40M	14.72M	13.00M	13.60M	12.17M	13.71M	13.71M	14.12M
Deferred Taxes (Quarter)	0.01M	-0.03M	-0.27M	0.35M	0.26M	-0.10M	-0.20M	0.01M	0.29M	-0.22M	-0.16M	-0.20M	0.40M	-0.33M	-0.32M	-8.61M	-1.21M	-0.17M	-0.70M	-1.11M
Gains from Investment Securities (Quarter)	5.74M	5.77M	0.05M	5.64M	7.08M	7.23M	6.95M	7.12M	8.80M	0.14M	2.46M	2.54M		0.05M	11.01M		0.23M	2.36M	0.68M	29.04M
Non-cash Items (Quarter)	2.77M	2.84M	3.07M	105.41M	3.23M	3.46M	3.39M	147.21M	4.10M	4.32M	4.62M	200.12M	5.42M	5.72M	5.98M	111.20M	6.55M	6.29M	6.40M	6.28M
Cash from Operations (Quarter)	-20.71M	-13.08M	-15.01M	-20.71M	-18.43M	-16.87M	-30.40M	-35.33M	-34.41M	-33.22M	-48.08M	-35.40M	-46.19M	-31.15M	-49.66M	-54.38M	-61.65M	-64.23M	-71.75M	-81.48M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)												-4.64M	0.31M	0.31M	0.32M	0.32M	0.32M	0.33M	0.33M	0.33M
Depreciation & Amortization (CF) (Quarter)	0.20M	0.23M	0.21M	0.27M	0.38M	0.38M	0.36M	0.30M	0.35M	0.60M	1.73M	-0.63M	0.59M	0.64M	0.67M	0.67M	0.66M	0.63M	0.64M	0.61M
Change in Working Capital
Change in Receivables (Quarter)	3.24M	-2.63M	0.33M	-0.48M	0.15M	-0.39M	-0.01M	-1.51M	-0.23M	-0.04M	-0.15M	0.29M	-0.04M	0.02M	0.08M	0.55M	7.18M	-7.56M	-0.28M	0.56M
Change in Accured Expenses (Quarter)	-3.21M	3.70M	-1.27M	3.76M	-5.80M	5.79M	2.06M	6.02M	-0.59M	5.58M	-3.36M	2.30M	-5.02M	9.15M	-4.13M	8.53M	-3.78M	0.87M	6.07M	0.04M
Investing Activities
Capital Expenditures (Quarter)	0.40M	0.91M	0.22M	0.51M	0.21M	0.54M	0.39M	1.75M	2.21M	2.13M	1.20M	0.08M	0.19M	1.51M	0.59M	0.78M	0.04M	0.16M	0.28M	0.32M
Change in Acquisitions & Divestments (Quarter)	45.95M	30.73M	25.80M	42.27M	20.28M	74.54M	61.04M	104.76M	157.11M	192.31M	201.85M	136.88M	133.84M	235.68M	165.18M	165.64M	165.79M	171.23M	113.51M	123.92M
Cash from Investing Activities (Quarter)	-55.10M	8.19M	15.57M	-215.43M	-48.89M	1.32M	-234.10M	-11.74M	46.62M	27.90M	53.88M	-239.79M	-43.19M	109.19M	0.50M	98.50M	34.51M	82.26M	38.53M	62.70M
Financing Activities
Other financing activities (Quarter)
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	0.11M	0.11M	0.03M	0.01M	7.88M			0.01M			29.51M	-29.47M				0.05M	1.15M	0.07M	2.36M	1.39M
Misc.
Cash from Financing Activities (Quarter)	118.72M	0.11M	4.76M	323.95M	7.88M	269.89M	0.70M	0.01M				324.01M				12.13M	1.15M	0.07M	2.36M	113.54M
Exchange Rate Effect (Quarter)	0.07M	-0.28M	-0.45M	0.07M	0.29M	-0.89M	-2.70M	0.81M	0.06M	0.36M	-0.29M	0.25M	-0.37M	-0.20M	0.05M	-1.16M	-0.06M	0.63M	-0.01M	-0.10M
Change in Cash (Quarter)	42.98M	-5.05M	4.88M	87.88M	-59.15M	253.45M	-266.50M	-46.25M	12.27M	-4.96M	35.02M	49.07M	-89.75M	77.84M	-49.11M	55.09M	-26.05M	18.72M	-30.87M	94.65M
Free Cash Flow (Quarter)	-21.11M	-13.99M	-15.23M	-21.22M	-18.64M	-17.41M	-30.79M	-37.08M	-36.62M	-35.35M	-49.28M	-35.48M	-46.38M	-32.67M	-50.26M	-55.17M	-61.70M	-64.39M	-72.03M	-81.80M
Net Cash Flow (Quarter)	42.91M	-4.77M	5.33M	87.81M	-59.44M	254.34M	-263.80M	-47.06M	12.21M	-5.32M	5.80M	48.82M	-89.38M	78.04M	-49.17M	56.25M	-25.99M	18.09M	-30.86M	94.75M

Research Tools

Xenon Pharmaceuticals Cash Flow Statement (2013-2025) | XENE

Create an account

Sign In

Reset Password